Aquestive therapeutics to hold virtual investor day to provide pipeline updates on september 27th

Warren, n.j., sept. 09, 2024 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (“aquestive” or the “company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced it will hold a virtual investor day on september 27, 2024 at 8:00 am et to discuss the company's pipeline updates, inclusive of anaphylm™ (epinephrine) sublingual film and aqst-108 (epinephrine) topical gel, both candidate products emerging from the company's adrenaverse™ epinephrine prodrug platform. the event will include presentations by members of the aquestive management team and by a distinguished key opinion leader j. david farrar, phd, associate professor, immunology/molecular biology, ut southwestern medical center.
AQST Ratings Summary
AQST Quant Ranking